Welcome to our dedicated page for AUNA S.A. news (Ticker: AUNA), a resource for investors and traders seeking the latest updates and insights on AUNA S.A. stock.
Auna S.A. (NYSE: AUNA) is a Latin American healthcare platform with operations in Mexico, Peru, and Colombia, and its news flow reflects both its medical activities and its capital markets presence. Company announcements describe a horizontally integrated network of hospitals, ambulatory centers, and prevention and wellness centers, together with a vertically integrated portfolio of oncological and general health plans. News about Auna often highlights developments in these facilities and plans, as well as initiatives related to prevention and complex diseases.
Investors and observers following AUNA news can expect regular updates on financial performance and operating trends. The company has issued press releases on quarterly financial results, including metrics such as revenue, adjusted EBITDA, and leverage ratios, and has discussed performance in its Peru, Colombia, and Mexico operations. These releases are typically furnished to the U.S. Securities and Exchange Commission on Form 6-K and provide detail on segment performance, health plan memberships, and demand for services in its healthcare network.
Auna’s news stream also covers financing and capital structure actions. The company has announced proposed and completed offerings of senior secured notes, a large debt refinancing, and cash tender offers and consent solicitations for existing notes. These items provide context on how Auna manages debt maturities, interest costs, and its stated medium-term leverage objectives.
Operational and strategic announcements are another key component of AUNA news. The company has reported the expansion of its OncoMexico network through partnerships with medical institutions across several Mexican cities and a collaboration with a digital preventive care platform. It has also announced a public–private partnership milestone related to Torre Trecca in Lima, Peru, and a Memorandum of Understanding with Sojitz Corporation of America to explore joint healthcare opportunities in Latin America, initially focused on Mexico.
For users tracking AUNA, the news feed offers a centralized view of Auna’s financial disclosures, regional healthcare initiatives, partnerships, and capital markets transactions, all based on the company’s own public communications.
Auna S.A. (NYSE: AUNA), a leading Latin American healthcare services and plan provider operating in Mexico, Peru, and Colombia, has announced its reporting schedule for Second Quarter 2024 financial results. The company will release its earnings report on Wednesday, August 21, 2024, after market close. A conference call is scheduled for the same day at 5:00 p.m. ET. Auna has also set a quiet period from August 2 to August 21, 2024. Interested parties can participate in the conference call via phone or webcast, with toll-free and international dial-in numbers provided.
Auna S.A. (NYSE: AUNA) has launched OncoSalud, the first integrated oncology insurance in Mexico, through its hospital network in Monterrey. This product, priced at an average of USD 40 per month, offers coverage up to USD 0.5 million annually for cancer prevention, detection, and treatment. It's designed for families with members up to 70 years old without pre-existing oncological conditions.
OncoSalud leverages Auna's 35 years of experience in Peru and Colombia, focusing on prevention and early detection with free preventive check-ups and diagnostic exams. The company estimates a total addressable market of up to 14 million people in Mexico, where cancer is the third leading cause of mortality. This initiative aims to transform access to oncology treatments and improve healthcare accessibility across the region.
Auna (NYSE: AUNA), a major player in Latin America's healthcare sector, announced its unaudited 1Q24 financial results. Revenue increased by 20% YoY to S/1,076 million, and operating profit rose by 26% to S/182 million. Adjusted EBITDA grew 14% YoY to S/241 million with a margin of 22.4%, though it decreased by 1.2 percentage points YoY. Net income improved to S/22 million from a break-even position in 1Q23.
Geographically, revenue growth was observed across all markets. In Peru, the adjusted EBITDA margin reached 20.4%, aligning with targets. Significant investments are being made in Mexico, particularly in Monterrey and the upcoming OncoMexico launch, expected to bolster returns in the latter half of 2024. The company forecasts adjusted EBITDA growth of 20% or more for the full year. The leverage ratio improved to 4.29x.
These financial results reflect Auna's integrated healthcare model's strength and its ability to generate substantial returns, emphasizing the company's commitment to modernizing healthcare in the region.
Auna S.A. (NYSE: AUNA), a prominent Latin American healthcare services and plan provider, has announced the reporting dates for its First Quarter 2024 financial results. The company operates in Mexico, Peru, and Colombia, with the earnings release scheduled for Wednesday, May 22, 2024, after market close. A conference call will take place the same day at 5:00 p.m. ET. A quiet period will be observed from Wednesday, May 8 to Wednesday, May 22, 2024.
Summary not available.
Summary not available.
Summary not available.